HBV related liver fibrosis
Conditions
Interventions
A:Anluohuaxian pill
B:Fufang Biejia Ruangan tablets
Sponsors
Guangdong Provincial Hospital of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) met the diagnostic criteria of chronic viral hepatitis B; (2) with syndrome of liver depression and spleen deficiency and blood stasis, deficiency of Qi and blood; (3) liver biopsy liver fibrosis stage of F less than 2, and the ALT less than 2ULN (the upper limit of normal value); (4) aged 18 to 65 \ years of age; both gender; (5) not taking nucleoside antiviral drugs, 6 months did not conduct anti fibrosis therapy; (6) signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Co infection with other viral liver diseases; (2) associated with other chronic severe hepatitis, decompensated cirrhosis, liver cancer and other serious or end-stage liver disease; (3) with heart, kidney, lung, blood, endocrine, metabolic, immune and gastrointestinal severe primary diseases or psychiatric patients; (4) pregnant or lactating women; (5) allergic or the use of traditional Chinese medicine allergic patients; (6) and not according to the prescribed medication, poor compliance, incomplete information affect the efficacy and safety of judge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver biopsy; | — |
Countries
China
Contacts
Public ContactXiaoling Chi
Outcome results
None listed